Work

Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML

Year: 2024

Type: article

Study design: Observational Study

Source: Leukemia

DOI: 10.1038/s41375-024-02175-0

Authors: Shai Shimony, Jan Philipp Bewersdorf, Rory M. Shallis, Yiwen Liu, Eva J. Schaefer, Amer M. Zeidan, Aaron D. Goldberg, Eytan M. Stein, Guido Marcucci, R. Coleman Lindsley, Evan C. Chen, Jorge Ramos Perez, Anthony Stein, Daniel J. DeAngelo, Donna S. Neuberg, Richard M. Stone, Brian Ball, Maximilian Stahl

Institutions: Tel Aviv University, Rabin Medical Center, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Yale Cancer Center, Smilow Cancer Hospital, National Center for Tumor Diseases, City Of Hope National Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4391982706

FWCI: 9.077

Cites: 27

Cited by: 34

Related to: 10